Shineway Pharmaceutical Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 186.0 | 138.5 | 107.6 |
| Cost of Goods Sold | 52.6 | 37.6 | 31.9 |
| Gross Profit | 133.4 | 100.9 | 75.8 |
| Gross Profit Margin | 71.7% | 72.9% | 70.4% |
| SG&A Expense | 54.9 | 46.3 | 8.7 |
| Depreciation & Amortization | -- | -- | 3.8 |
| Operating Income | -- | -- | -- |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 4.8 | 28.3 | 5.9 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 69.5 | 78.7 | 49.5 |
| Income Taxes | 11.4 | 11.7 | 6.9 |
| Net Income After Taxes | 58.1 | 67.1 | 42.6 |
| Continuing Operations | 58.1 | 67.1 | 42.6 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 58.1 | 67.1 | 42.6 |
| Total Net Income | 58.1 | 67.1 | 42.6 |
| Net Profit Margin | 31.2% | 48.4% | 39.6% |
| Diluted EPS from Total Net Income ($) | 0.07 | 0.08 | 0.05 |
| Dividends per Share | 0.02 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
